Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5854479 | 0.88 | HTR2A (0.48) | ABCB1SLC2A1L3MBTL1HTR2ACHRM2 | |
| SCHEMBL17757709 | 0.88 | CHRM2 (0.47) | SLC6A4SLC2A1L3MBTL1CHRM2 | |
| SCHEMBL4109207 | 0.87 | ABCB1 (0.43) | ABCB1SLC2A1L3MBTL1HTR2ACHRM2 | |
| SCHEMBL15471003 | 0.84 | SMN1; SMN2 (0.49) | ABCB1SLC2A1MEN1KMT2A | |
| SCHEMBL10296005 | 0.84 | MC4R (0.50) | HTR2ACHRM2 | |
| SCHEMBL13913292 | 0.84 | KDM4E (0.47) | ABCB1SLC2A1L3MBTL1HTR2ACHRM2 | |
| SCHEMBL10296006 | 0.84 | MC4R (0.50) | HTR2ACHRM2 | |
| SCHEMBL14543901 | 0.83 | ABCB1 (0.45) | ABCB1SLC2A1L3MBTL1HTR2AMEN1 | |
| SCHEMBL14543963 | 0.83 | MC4R (0.53) | HTR2A | |
| Hydrochloric Acid SCHEMBL15821262 | 0.83 | CYP1A2 (0.49) | ABCB1SLC2A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090069441-A1 | Motuporamine Mimic Agents | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2009-03-12 | — | — | US | claimed |
| US-20090069441-A1 | Motuporamine Mimic Agents | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069441-A1 | Motuporamine Mimic Agents | MYADM, CD99, HNMT | SLC6A4 855/4885ABCB1 758/4885HRH1 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.